Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
2seventy bio, Inc. TSVT
$11.33
-$0.43 (-3.82%)
На 18:04, 12 мая 2023
+129.48%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
569654230.00000000
-
week52high
18.88
-
week52low
8.25
-
Revenue
91496000
-
P/E TTM
0
-
Beta
0.00000000
-
EPS
-7.63000000
-
Last Dividend
0.00000000
-
Next Earnings Date
03 мая 2023 г. в 20:30
Описание компании
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Morgan Stanley | Overweight | Overweight | 15 авг 2022 г. |
| Morgan Stanley | Overweight | Overweight | 15 июл 2022 г. |
| Morgan Stanley | Overweight | Overweight | 17 мая 2022 г. |
| Goldman Sachs | Buy | 02 мая 2022 г. | |
| SVB Leerink | Outperform | 10 февр 2022 г. | |
| Guggenheim | Buy | 31 окт 2022 г. | |
| SVB Leerink | Outperform | Outperform | 08 ноя 2022 г. |
| Morgan Stanley | Overweight | Overweight | 08 ноя 2022 г. |
| SVB Leerink | Outperform | Outperform | 10 янв 2023 г. |
| Morgan Stanley | Overweight | Overweight | 24 янв 2023 г. |
| Goldman Sachs | Buy | Buy | 20 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Leschly Nick | A | 162500 | 162500 | 01 февр 2023 г. |
| Leschly Nick | A | 1044214 | 428571 | 01 февр 2023 г. |
| Leschly Nick | A | 615643 | 81250 | 01 февр 2023 г. |
| Baird William D III | A | 50000 | 50000 | 01 февр 2023 г. |
| Baird William D III | A | 210940 | 107143 | 01 февр 2023 г. |
| Baird William D III | A | 103797 | 25000 | 01 февр 2023 г. |
| Gregory Philip D | A | 50000 | 50000 | 01 февр 2023 г. |
| Gregory Philip D | A | 267375 | 142857 | 01 февр 2023 г. |
| Gregory Philip D | A | 124518 | 25000 | 01 февр 2023 г. |
| Leschly Nick | D | 536419 | 6587 | 12 янв 2023 г. |
Новостная лента
2seventy bio A Buy For Abecma And CAR T Platform
Seeking Alpha
09 дек 2022 г. в 12:17
Abecma U.S. sales in Q3 by BMS were $75 million. 2seventy bio is working on label expansion for Abecma.
2seventy bio, Inc. (TSVT) Reports Q3 Loss, Tops Revenue Estimates
Zacks Investment Research
07 ноя 2022 г. в 18:56
2seventy bio, Inc. (TSVT) delivered earnings and revenue surprises of -1.15% and 25.71%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
2seventy bio to Present Data from KarMMa-2 Study of Abecma (idecabtagene vicleucel) at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition
Business Wire
03 ноя 2022 г. в 09:06
CAMBRIDGE, Mass.
2seventy Bio: This Spinoff In The CAR-T Space Is Attractive
Seeking Alpha
08 сент 2022 г. в 18:39
Shares have lost over 40% of their value since the spinoff in November. The pipeline has multiple shots on goal including in solid tumors and AML plus validating partnerships via Regeneron and BMY.
2seventy bio to Participate in Upcoming Investor Conferences
Business Wire
31 авг 2022 г. в 07:30
CAMBRIDGE, Mass.--(BUSINESS WIRE)--2seventy bio, Inc. (Nasdaq: TSVT), a leading immuno-oncology cell therapy company, announced today that members of the management team will participate in the following upcoming investor conferences: 17th Annual Citi BioPharma Conference, “Cell Therapy Part 1” panel on Wednesday, September 7, 2022 at 9:40am ET in Boston, MA 2022 Morgan Stanley Global Healthcare Conference, fireside chat on Wednesday, September 14, 2022 at 11:45am ET in New York, NY Live webcas